Anna Perols
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
-
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 10
- Radiopharmaceutical Chemistry and Applications 8
- Oncology 3
- HER2/EGFR in Cancer Research 2
- Co-authors
- Amelie Eriksson Karlström (15 shared papers)Vladimir Tolmachev (11 shared papers)Anna Orlova (11 shared papers)Hadis Honarvar (5 shared papers)Joanna Strand (4 shared papers)Mohamed Altai (5 shared papers)Mattias Sandström (3 shared papers)Ram Kumar Selvaraju (3 shared papers)
In The Last Decade
Anna Perols
15 papers receiving 406 citations
Peers
Comparison fields: 5 of 55
- Radiology, Nuclear Medicine and Imaging 276
- Oncology 124
- Biophysics 20
- Structural Biology 5
- Organic Chemistry 60
Countries citing papers authored by Anna Perols
This map shows the geographic impact of Anna Perols's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Perols with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Perols more than expected).
Fields of papers citing papers by Anna Perols
This network shows the impact of papers produced by Anna Perols. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Perols. The network helps show where Anna Perols may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Perols, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 56 | |
| 2 | 2013 | 55 | |
| 3 | 2017 | 53 | |
| 4 | 2014 | 42 | |
| 5 | 2012 | 41 | |
| 6 | 2011 | 39 | |
| 7 | 2014 | 29 | |
| 8 | 2011 | 24 | |
| 9 | 2011 | 17 | |
| 10 | 2014 | 15 | |
| 11 | 2018 | 14 | |
| 12 | 2016 | 12 | |
| 13 | 2015 | 12 | |
| 14 | Evaluation of a maleimido derivative of NODAGA for site-specific In-111-labeling of Affibody molecules | 2011 | 2 |
| 15 | Influence of DOTA chelator position on biodistribution and targeting properties of 111 In-labelled anti-HER2 affibody molecules | 2012 | 1 |
About Anna Perols
Anna Perols is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology, Biophysics and Organic Chemistry, having authored 15 papers that have together received 412 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (10 papers), Radiopharmaceutical Chemistry and Applications (8 papers), Glycosylation and Glycoproteins Research (2 papers), Click Chemistry and Applications (2 papers), Chemical Synthesis and Analysis (2 papers), HER2/EGFR in Cancer Research (2 papers), Microfluidic and Bio-sensing Technologies (1 paper) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (276 citations), Oncology (124 citations), Biophysics (20 citations), Structural Biology (5 citations) and Organic Chemistry (60 citations). Anna Perols has collaborated with scholars based in Sweden, Finland and France. Frequent co-authors include Amelie Eriksson Karlström, Vladimir Tolmachev, Anna Orlova, Hadis Honarvar, Joanna Strand, Mohamed Altai, Mattias Sandström, Ram Kumar Selvaraju, Merja Haaparanta‐Solin and Cheng‐Bin Yim. Their work appears in journals such as Bioconjugate Chemistry, European Journal of Nuclear Medicine and Molecular Imaging, Scientific Reports, Biosensors and Bioelectronics and ChemBioChem.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.